Sept. 27, 2022 Price forecast | 2 weeks: 0.64% | 1 month: -0.63% | 3 months: 4.23%


MEDP stock forecast

Our latest prediction for Medpace Holdings Inc's stock price was made on the Sept. 27, 2022 when the stock price was at 147.03$.

In the short term (2weeks), MEDP's stock price should outperform the market by 0.64%. During that period the price should oscillate between -8.84% and +5.63%.

In the medium term (3months), MEDP's stock price should outperform the market by 4.23%. During that period the price should oscillate between -28.23% and +22.07%.

Create a solid portfolio with MEDP

Add MEDP to your portfolio and optimize it!


About Medpace Holdings Inc

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries.

At the moment the company generates 163M USD in revenues.

On its last earning announcement, the company reported a profit of 6.01$ per share.

The book value per share is 15.18$

Medpace Holdings Inc website


Three months stock forecastSept. 27, 2022


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
163M - 233M 142.88% 187M 6.01 - - 30M 15.18 - - -